RT
Ribon Therapeutics
The startup has developed a biopharmaceutical platform that creates small molecule inhibitors targeting cancer cell survival mechanisms under stress. This technology aims to enhance treatment options for patients suffering from various forms of cancer by directly disrupting the fundamental processes that allow cancer cells to thrive.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$198.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a biopharmaceutical platform that creates small molecule inhibitors targeting cancer cell survival mechanisms under stress. This technology aims to enhance treatment options for patients suffering from various forms of cancer by directly disrupting the fundamental processes that allow cancer cells to thrive.